Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 1283.00 | 2583.25 | 0.4967 | 0.0544 |
SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2865.00 | 2583.25 | 1.1091 | 1.1987 |
SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2687.00 | 2583.25 | 1.0402 | 1.0734 |
SK-BR-3 | Nilotinib | 10 | uM | 3 | 1250.00 | 1210.88 | 1987.00 | 2583.25 | 0.7692 | 0.5732 |
SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 1250.00 | 1210.88 | 2841.00 | 2583.25 | 1.0998 | 1.1818 |
SK-BR-3 | Nilotinib | 1 | uM | 3 | 1250.00 | 1210.88 | 2691.00 | 2583.25 | 1.0417 | 1.0762 |
SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2838.00 | 2583.25 | 1.0986 | 1.1797 |
SK-BR-3 | PLX-4720 | 10 | uM | 3 | 1250.00 | 1210.88 | 2465.00 | 2583.25 | 0.9542 | 0.9161 |
SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 1267.00 | 2583.25 | 0.4905 | 0.0423 |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2976.00 | 2583.25 | 1.1520 | 1.2765 | |
SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1300.00 | 2583.25 | 0.5032 | 0.0671 |
SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2626.00 | 2583.25 | 1.0165 | 1.0303 |
SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 2434.00 | 2583.25 | 0.9422 | 0.8940 |
SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1258.00 | 2583.25 | 0.4870 | 0.0355 |
SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 1250.00 | 1210.88 | 904.00 | 2583.25 | 0.3500 | -0.2346 |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2818.00 | 2583.25 | 1.0909 | 1.1656 | |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2352.00 | 2583.25 | 0.9105 | 0.8356 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4109.00 | 4603.75 | 0.8925 | 0.7695 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4786.00 | 4603.75 | 1.0396 | 1.0854 | |
SK-BR-3 | Etoposide | 10 | uM | 3 | 2500.00 | 2418.67 | 1874.00 | 4603.75 | 0.4071 | -0.2403 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4509.00 | 4603.75 | 0.9794 | 0.9557 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4510.00 | 4603.75 | 0.9796 | 0.9562 | |
SK-BR-3 | Etoposide | 1 | uM | 3 | 2500.00 | 2418.67 | 2330.00 | 4603.75 | 0.5061 | -0.0394 |
SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4600.00 | 4603.75 | 0.9992 | 0.9983 |
SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4814.00 | 4603.75 | 1.0457 | 1.0985 |